Fertility Blend Clinical Studies

Fertility Blend Clinical Studies

Buy FertilityBlend for Women | Buy FertilityBlend for Men
ONGOING CLINICAL STUDY

Below is a summary of an ongoing clinical study on FertilityBlend, with the diagnostic tests being conducted and validated at the Stanford University School of Medicine . After 3 months in the study, 3 of the 9 women (33%) in the active treatment group became pregnant, and none (0%) of the 7 women in the placebo group achieved pregnancy (placebo group received equivalent of sugar pill instead of treatment). The study includes only women that have failed to conceive after trying for 6 to 36 months prior to taking part in the study.

CLINICAL STUDY OF FERTILITY BLEND, A NUTRITIONAL SUPPLEMENT USED FOR THE OPTIMIZATION OF REPRODUCTIVE HEALTH IN WOMEN.
SB Mooney, ML Polan, AS Trant

Objective: To determine the impact of nutritional supplementation on the optimization of reproductive health in women.

Design: A double-blind, placebo-controlled clinical pilot study was initiated to determine the effects of Fertility Blend, a proprietary, natural nutritional supplement containing chasteberry and green tea extracts, the amino acid- L-arginine, vitaminsE, B6, B12 and folate, iron, magnesium, zinc and selenium. Changes in mid-luteal progesterone level and basal body temperature, as well as length of menstrual cycle, pregnancy rate and incidence of side effects were monitored.



Results: Sixteen (16) women, age 26-45 years, who have tried unsuccessfully to conceive for 6 to 36 months were enrolled in the study. None of the participants received any pharmacological treatments for infertility during the course of the study. Of the 16, 7 received placebo and 9 received Fertility Blend. After 3 months, an increase in mean mid-luteal progesterone levels was noted in the supplement group (from 5.9 to 13.2 ng/ml, p=0.08). Supplement group also demonstrated an increase in the average number of days in cycle with luteal phase temperatures over 98F on their basal temperature charts (4.8 to 8.3 days), and showed reductions in their mean cycle length (33 to 29 days). The placebo group did not show any notable changes, before or after treatment, in any of the parameters studied. By the end of the 3 months study, 3 of the 9 women in the supplement group were pregnant (33%), and none of the 7 women in the placebo group were pregnant (0%).

Conclusion: Nutritional supplementation may provide an alternative or adjuvant to conventional infertility therapies. With few side effects, this supplement is an attractive option for use in the management and optimization of reproductive health in women. Enrollment of patients is ongoing with a goal of evaluating at least 100 women. Similarly, evaluation of a nutritional blend formulated for men is planned, to determine its effect on sperm concentration and motility.




Clinical Studies for Fertility Blend for Women

  • Brown DJ. 1995. Vitex agnus castus. Clinical Monograph. Townsend Letters for Doctors and Patients, October.
  • Propping D, et al. 1988. Diagnosis and therapy of corpus luteum insufficiency in general practice. Therapiewoche 38:2992-3001.
  • Caan B, et al. 1998. Differences in fertility associated with caffeinated beverage consumption. Am J Public Health 88(2):270-4.
  • Bayer R. 1960. Treatment of infertility with vitamin E. Int J Fertil 5:70-8.
  • Rushton DH, et al. 1991. Ferritin and fertility. Lancet 337:1554.
  • McCloud D. 1996. Female infertility: a holistic approach. Aust J Med Herbalism 8(3):68-77.
  • Czeizel AE. 1998. Periconceptual folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 78(2):151-61.





Clinical Studies for Fertility Blend for Men

  • Costa M, et al. 1994. L-carnitine in ideopathic asthenospermia: a multicenter study. Andrologia 26:155-9.
  • Zheng R-L and Zhang H. 1997. Effects of ferulic acid on fertile and asthenozoospermic infertile human sperm motility, viability, lipid peroxidation, and cyclic nucleotides. Free Rad Biol & Med 22(4):581-6.
  • Kessopoulou E, et al. 1995. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated with male infertility. Fertil & Steril 64(4):825-31.
  • Geva E, et al. 1996. The effect of antioxidant treatment on human spermatazoa and fertilization rate in an in vitro fertilization program. Fertil & Steril 66(3):430-4.
  • Dawson EB, et al. 1992. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil & Steril 58(5):1034-9.
  • Scott R, et al. 1998. The effect of oral selenium supplementation on human sperm motility. Br J Urol 82:76-80.
  • Moriyama H, et al. 1987. Studies on the usefulness of a long-term, high-dose treatment of methylcobalamin in patients with oligozoospermia. Hin Kiyo 33(1):151-6.
  • Takihara H, et al. 1987. Zinc sulphate therapy for infertile male with or without varicocelectomy. Urol 29(6):638-41.
  • Czeizel AE. 1998. Periconceptual folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 78(2):151-61.